Pfizer (PFE) Shares Issued (2012 - 2020)
Pfizer (PFE) reported Shares Issued of $206.0 million for Q3 2020, up 274.55% year-over-year from $55.0 million in Q3 2019, and up 505.88% quarter-over-quarter from $34.0 million in Q2 2020.
Pfizer (PFE) Shares Issued (2012 - 2020) Analysis & Trends
Pfizer (PFE) has 9 years of Shares Issued data on file, last reported at $206.0 million in Q3 2020.
- Shares Issued for Q3 2020 came in at $206.0 million, up 274.55% year-over-year; the trailing twelve-month figure through Sep 2020 was $455.0 million (down 1.73% YoY), and the FY2020 annual result was $425.0 million, up 7.87% from the prior year.
- Shares Issued grew to $206.0 million in Q3 2020 per PFE's latest filing, from $34.0 million in the prior quarter.
- Over five years, Shares Issued peaked at $625.0 million in Q3 2018 and troughed at $34.0 million in Q2 2020.
- A 5-year average of $205.2 million and a median of $160.0 million in 2018 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2019 and 2020: Shares Issued plunged 91.2% in 2019, then jumped 274.55% in 2020.
- A 5-year view of Shares Issued shows it stood at $73.0 million in 2016, then jumped by 182.19% to $206.0 million in 2017, then fell by 22.33% to $160.0 million in 2018, then slumped by 43.12% to $91.0 million in 2019, then surged by 126.37% to $206.0 million in 2020.
- Business Quant data shows PFE's Shares Issued at $206.0 million in Q3 2020, $34.0 million in Q2 2020, and $124.0 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 10.79 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 1.17 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 157.00 Mn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 166.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2020 | 206.00 Mn |
| Sep 27, 2020 | 206.00 Mn |
| Jun 28, 2020 | 34.00 Mn |
| Jun 28, 2020 | 34.00 Mn |
| Mar 29, 2020 | 124.00 Mn |
| Mar 29, 2020 | 124.00 Mn |
| Dec 31, 2019 | 91.00 Mn |
| Dec 31, 2019 | 91.00 Mn |
| Sep 29, 2019 | 55.00 Mn |
| Sep 29, 2019 | 55.00 Mn |
| Jun 30, 2019 | 122.00 Mn |
| Jun 30, 2019 | 122.00 Mn |
| Mar 31, 2019 | 126.00 Mn |
| Mar 31, 2019 | 126.00 Mn |
| Dec 31, 2018 | 160.00 Mn |
| Dec 31, 2018 | 160.00 Mn |
| Sep 30, 2018 | 625.00 Mn |
| Sep 30, 2018 | 625.00 Mn |
| Jul 1, 2018 | 102.00 Mn |
| Jul 1, 2018 | 102.00 Mn |